Lexicon Pharmaceuticals
1995
FOUNDED
PUBLIC
STATUS
201-300
EMPLOYEES
LXRX
STOCK SYMBOL
3
INVESTMENTS
$2.94
SHARE PRICE
(As of Tuesday Closing)
Description
Lexicon Pharmaceuticals is a biopharmaceutical company that uses mouse genetics to discover the function of genes and find promising drug targets. Lexicon then designs and develops drugs for these targets, which cover a broad spectrum of therapeutic areas. Following a restructuring in January 2014, Lexicon focused efforts on two drugs: sotagliflozin in diabetes, which is partnered with Sanofi, and Xermelo (telotristat etiprate) in carcinoid syndrome, which is partnered with Ipsen outside the U.S. Early-stage programs include SGLT1 inhibitor LX2761 and neuropathic pain drug LX9211.
Website
Formerly Known As
Lexicon Genetics
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
- 8800 Technology Forest Place
- The Woodlands, TX 77381
- United States
+1 (281) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Lexicon Pharmaceuticals’s full profile, request a free trial.
Lexicon Pharmaceuticals Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.12 - $11.51 | $312M | $2.74 | -$0.84 | 1.81M | 106M |
Lexicon Pharmaceuticals Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 780,332 | 760,993 | 946,535 | 1,145,097 |
| Revenue | 43,147 | 63,209 | 91,689 | 79,256 |
| EBITDA | (67,257) | (99,596) | (127,225) | (125,115) |
| Net Income | (88,582) | (120,548) | (122,993) | (131,445) |
| Total Assets | 233,143 | 284,136 | 436,539 | 475,625 |
| Total Debt | 245,068 | 245,002 | 245,670 | 101,447 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Lexicon Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Lexicon Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookLexicon Pharmaceuticals Competitors (39)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regulus Therapeutics | Corporation | San Diego, CA | 00 | 00000 | 000000000 | 00000 |
| 000000000(00000000 | Formerly VC-backed | New York, NY | 000 | 00000 | 00000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Cambridge, MA | 0000 | 00.000 | 00000000 | 00.000 |
| 000000000000 00000 | Corporate Backed or Acquired | Trevose, PA | 000 | 00000 | 00000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000000 | 00000 |
Lexicon Pharmaceuticals Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 02-Aug-2010 | 000000000000000000 | 0000 | Pharmaceuticals | 000000 00000 00.0 |
| 00000000 0000 | 01-Jun-2007 | 00000 0000000 | Pharmaceuticals | 000000 00000 00.0 | |
| Coelacanth Chemical | 12-Jul-2001 | Merger/Acquisition | 0000 | Pharmaceuticals | 000000 00000 00.0 |
Lexicon Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Lexicon Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookLexicon Pharmaceuticals Executive Team (11)
5 Former Executives
You’re viewing 5 of 11 executives. Get the full list »Lexicon Pharmaceuticals Board Members (9)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000 0000 00 | Self | Board Member | 000 0000 | |
| 00000000000 0000000 | The Invus Group | Board Member | 000 0000 | |
| 00000 000000000 | Self | Board Member | 000 0000 | |
| 000000 00000 | Self | Board Member | 000 0000 | |
| 000000 00000 | Lexicon Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |